These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31121994)

  • 61. A multiinstitutional study of the effects of medical therapy for lower urinary symptoms on the perioperative outcomes of holmium laser enucleation of the prostate.
    Warner JN; Nunez RN; Tyson MD; Viprakasit DP; Miller NL; Humphreys MR
    Urology; 2011 Dec; 78(6):1385-90. PubMed ID: 21871654
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics.
    Roehrborn CG; Nuckolls JG; Wei JT; Steers W;
    BJU Int; 2007 Oct; 100(4):813-9. PubMed ID: 17822462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
    Nygård LH; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate; 2017 Jun; 77(9):1029-1035. PubMed ID: 28480542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Five-alpha reductase inhibitor influences expression of androgen receptor and HOXB13 in human hyperplastic prostate tissue.
    Jung C; Park Y; Kim YR; Ryu SB; Kang TW
    Int Braz J Urol; 2013; 39(6):875-83. PubMed ID: 24456780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia.
    De Nunzio C; Presicce F; Tubaro A
    Drugs Today (Barc); 2016 Sep; 52(9):501-517. PubMed ID: 27883117
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy.
    Lazzeri M; Duga S; Azzolini E; Fasulo V; Buffi N; Saita A; Lughezzani G; Paraboschi EM; Hurle R; Nobili A; Cecconi M; Guazzoni G; Casale P; Asselta R;
    Minerva Urol Nephrol; 2022 Feb; 74(1):77-84. PubMed ID: 33439572
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design.
    Siami P; Roehrborn CG; Barkin J; Damiao R; Wyczolkowski M; Duggan A; Major-Walker K; Morrill BB;
    Contemp Clin Trials; 2007 Nov; 28(6):770-9. PubMed ID: 17761460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk stratification for benign prostatic hyperplasia (BPH) treatment.
    Emberton M; Fitzpatrick JM; Rees J
    BJU Int; 2011 Mar; 107(6):876-80. PubMed ID: 21265993
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study.
    Pyun JH; Son NH; Ko YH; Kim SW; Kim H; Bae YJ
    World J Mens Health; 2024 Apr; 42(2):460-466. PubMed ID: 38164032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Peng CH; Yang YS; Chan KC; Kornelius E; Chiou JY; Huang CN
    Intern Med; 2017; 56(9):1015-1021. PubMed ID: 28458305
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.
    Azoulay L; Eberg M; Benayoun S; Pollak M
    JAMA Oncol; 2015 Jun; 1(3):314-20. PubMed ID: 26181177
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis.
    Lyon M; Li J; Cullen J; Milinovich A; Kattan M; Jehi L; Sharifi N; Klein EA
    J Urol; 2022 Jan; 207(1):183-189. PubMed ID: 34433301
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery.
    Boyle P; Roehrborn C; Harkaway R; Logie J; de la Rosette J; Emberton M
    Eur Urol; 2004 May; 45(5):620-6; discussion 626-7. PubMed ID: 15082205
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea.
    Jung M; Lee S
    Drugs Aging; 2020 Jan; 37(1):43-55. PubMed ID: 31755069
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term Cardiovascular Disease Risk Among Firefighters After the World Trade Center Disaster.
    Cohen HW; Zeig-Owens R; Joe C; Hall CB; Webber MP; Weiden MD; Cleven KL; Jaber N; Skerker M; Yip J; Schwartz T; Prezant DJ
    JAMA Netw Open; 2019 Sep; 2(9):e199775. PubMed ID: 31490535
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study.
    Peng YH; Huang CW; Liao WC; Chen HJ; Yin MC; Huang YM; Wu TN; Ho WC
    BMJ Open; 2017 Jun; 7(6):e015581. PubMed ID: 28645971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suicide and Intentional Self-harm Among Older Men Treated With 5-Alpha Reductase Inhibitor or Alpha-blockers for Benign Prostatic Hyperplasia.
    Pennap D; Mosholder AD; Ajao A; Boley E; Dharmarajan S; Akhtar S; Naik KB; Flowers N; Wernecke M; MaCurdy TE; Kelman JA; Graham DJ
    Urology; 2024 Jun; ():. PubMed ID: 38880345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.